MoleculeMind Breaks Nanobody Design Barrier
AI platform MMDesign achieves 90% success rate in de novo nanobody design, accelerating biologic drug discovery.
1 articles about 'Protein Design'
AI platform MMDesign achieves 90% success rate in de novo nanobody design, accelerating biologic drug discovery.